{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:47:33Z","timestamp":1782841653603,"version":"3.54.5"},"reference-count":25,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Interact J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Objective indicators are urgently needed to evaluate and monitor disease progression in patients with psoriasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to verify the correlations between blood count\u2013derived inflammatory markers and the Psoriasis Area and Severity Index (PASI) among patients with psoriasis and explore the value of applying the PASI in combination with proinflammatory factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a cross-sectional observational study that enrolled 719 patients from 2 tertiary hospitals. Receiver operating characteristic curve analysis and binary logistic regression models were applied to assess the evaluative power of blood count\u2013derived inflammatory markers and their consistency with the PASI for stratifying psoriasis severity. The association with the PASI and the combination with proinflammatory factors of the blood count\u2013derived inflammatory markers in 60 patients were analyzed. The exploratory association between blood count\u2013derived markers and proinflammatory factors was analyzed using product terms. To ensure robustness, multivariable combined models were evaluated using receiver operating characteristic curves and decision curve analysis. Model performance was further validated via calibration plots and a predictive nomogram, with the decision curve analysis net benefit axis increased to 1.0 for comprehensive visualization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The area under the curve showed that the systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI) were effective in reflecting psoriasis severity and showed advantages in patients with psoriasis complicated by arthritis and cardiovascular metabolic diseases. The comprehensive test showed quite appropriate consistency of the SIRI and PASI in distinguishing severity. The SII, SIRI, and AISI were significantly correlated with interleukin (IL)-6 in lesions (all\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.05), and the combinations of these indices with IL-6, IL-1, and IL-17 were also significantly correlated with the PASI (all\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Blood count\u2013derived inflammatory markers could better reflect the inflammation of patients with psoriasis. The SII, SIRI, and AISI have important clinical significance in evaluating disease severity. The combination with proinflammatory factors showed an advantage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/86454","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:24:01Z","timestamp":1778779441000},"page":"e86454-e86454","source":"Crossref","is-referenced-by-count":0,"title":["Value of Blood Count\u2013Derived Inflammatory Markers for Evaluating Psoriasis Severity: Pilot Cross-Sectional Observational Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2591-7926","authenticated-orcid":false,"given":"Luyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8753-1084","authenticated-orcid":false,"given":"Xiaorui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5196-7432","authenticated-orcid":false,"given":"Chuangang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6440-7270","authenticated-orcid":false,"given":"Wenyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6348-5750","authenticated-orcid":false,"given":"Qiuju","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0316-162X","authenticated-orcid":false,"given":"Wen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8139-6702","authenticated-orcid":false,"given":"Youkun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"10281","key":"R1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","journal-title":"Lancet"},{"issue":"4","key":"R2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/bjd.21627","article-title":"Biomarkers of disease progression in people with psoriasis: a scoping review","volume":"187","author":"Ramessur","journal-title":"Br J Dermatol"},{"issue":"1","key":"R3","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-021-00454-4","article-title":"Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and other hematological parameters in psoriasis patients","volume":"22","author":"Wang","journal-title":"BMC Immunol"},{"issue":"14","key":"R4","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/cncr.30057","article-title":"A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy","volume":"122","author":"Qi","journal-title":"Cancer"},{"issue":"23","key":"R5","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","journal-title":"Clin Cancer Res"},{"issue":"6","key":"R6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/ans.14557","article-title":"Inflammatory cell indexes as preoperative predictors of hospital stay in open elective thoracic surgery","volume":"88","author":"Paliogiannis","journal-title":"ANZ J Surg"},{"issue":"1","key":"R7","doi-asserted-by":"publisher","DOI":"10.3390\/life14010114","article-title":"Impact of blood-count-derived inflammatory markers in psoriatic disease progression","volume":"14","author":"Tiuc\u0103","journal-title":"Life (Basel)"},{"issue":"1","key":"R8","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1401a65","article-title":"Effect of treatment with biologic agents on the novel inflammatory biomarkers systemic immune inflammation index and systemic inflammation response index for psoriasis","volume":"14","author":"Tamer","journal-title":"Dermatol Pract Concept"},{"issue":"4","key":"R9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.14744\/SEMB.2023.43569","article-title":"Could blood cell-based inflammatory markers be used to monitor response to biologic therapy in psoriasis?","volume":"57","author":"Kulakli","journal-title":"Sisli Etfal Hastan Tip Bul"},{"issue":"23","key":"R10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242316898","article-title":"Predictive performances of blood-count-derived inflammatory markers for liver fibrosis severity in psoriasis vulgaris","volume":"24","author":"Tiuc\u0103","journal-title":"Int J Mol Sci"},{"issue":"4","key":"R11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/jdv.15339","article-title":"Severity, heterogeneity and systemic inflammation in psoriasis","volume":"33","author":"Christophers","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"R12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","article-title":"A critical role of the IL-1\u03b2-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis","volume":"139","author":"Cai","journal-title":"J Invest Dermatol"},{"issue":"7","key":"R13","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00109-021-02073-3","article-title":"Soluble IL-6R-mediated IL-6 trans-signaling activation contributes to the pathological development of psoriasis","volume":"99","author":"Xu","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/tjem.tjem_198_23","article-title":"Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: an extensive literature review","volume":"24","author":"Islam","journal-title":"Turk J Emerg Med"},{"issue":"8","key":"R15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12083046","article-title":"Impact of pretreatment systemic inflammatory markers on treatment persistence with biologics and conventional systemic therapy: a retrospective study of patients with psoriasis vulgaris and psoriatic arthritis","volume":"12","author":"Sugimoto","journal-title":"J Clin Med"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02376","article-title":"Neutrophils in psoriasis","volume":"10","author":"Chiang","journal-title":"Front Immunol"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1238647","article-title":"Platelet activation: a promoter for psoriasis and its comorbidity, cardiovascular disease","volume":"14","author":"Jiang","journal-title":"Front Immunol"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1043380","article-title":"Exploring the association and causal effect between white blood cells and psoriasis using large-scale population data","volume":"14","author":"Zhou","journal-title":"Front Immunol"},{"issue":"3","key":"R19","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-02823-6","article-title":"Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in psoriasis: a systematic review and meta-analysis","volume":"316","author":"Ye","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"R20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jcct.2020.12.006","article-title":"Association of neutrophil-to-lymphocyte ratio with non-calcified coronary artery burden in psoriasis: findings from an observational cohort study","volume":"15","author":"Dey","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"6","key":"R21","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14101","article-title":"The utility of systemic-immune inflammation index for predicting the disease activation in patients with psoriasis","volume":"75","author":"Dincer Rota","journal-title":"Int J Clin Pract"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1323174","article-title":"Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANES","volume":"15","author":"Ma","journal-title":"Front Immunol"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S437936","article-title":"Association of complete blood cell count-derived inflammatory biomarkers with psoriasis and mortality","volume":"16","author":"Zhao","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"6","key":"R24","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-02994-2","article-title":"Associations of novel complete blood count-derived inflammatory markers with psoriasis: a systematic review and meta-analysis","volume":"316","author":"Liu","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"R25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.12865\/CHSJ.46.04.05","article-title":"Systemic immune-inflammation index (SII) predicts increased severity in psoriasis and psoriatic arthritis","volume":"46","author":"Yorulmaz","journal-title":"Curr Health Sci J"}],"container-title":["Interactive Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.i-jmr.org\/2026\/1\/e86454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:14:19Z","timestamp":1782839659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.i-jmr.org\/2026\/1\/e86454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":25,"URL":"https:\/\/doi.org\/10.2196\/86454","relation":{},"ISSN":["1929-073X"],"issn-type":[{"value":"1929-073X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"article-number":"v15i10281e86454"}}